Papillomavirus Infection Clinical Trials

4 recruiting

Papillomavirus Infection Trials at a Glance

16 actively recruiting trials for papillomavirus infection are listed on ClinicalTrialsFinder across 6 cities in 11 countries. The largest study group is Not Applicable with 8 trials, with the heaviest enrollment activity in Houston, Oklahoma City, and Atlanta. Lead sponsors running papillomavirus infection studies include National Cancer Institute (NCI), The Institute of Molecular and Translational Medicine, Czech Republic, and Louisiana State University Health Sciences Center in New Orleans.

Browse papillomavirus infection trials by phase

Treatments under study

About Papillomavirus Infection Clinical Trials

Looking for clinical trials for Papillomavirus Infection? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Papillomavirus Infection trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Papillomavirus Infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Not Applicable

Digital Telecytology for Triage of HPV-Positive Women in Cameroon

Human Papillomavirus InfectionCervical Cancer Screening MethodsCervical Intraepithelial Neoplasia Grade 2 (CIN2)
University Hospital, Geneva1,800 enrolled2 locationsNCT07550010
Recruiting
Not Applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01)

Cervical CarcinomaHuman Papillomavirus Infection
National Cancer Institute (NCI)750 enrolled15 locationsNCT06498661
Recruiting
Not Applicable

Self-sampling for Non-attenders to Cervical Cancer Screening

Cervical CancerCervical DysplasiaHuman Papillomavirus Infection
The Institute of Molecular and Translational Medicine, Czech Republic15,000 enrolled1 locationNCT04226313
Recruiting
Not Applicable

Point of Care - Triage and Treatment for Cervical Pre-cancer

Cervical Intraepithelial NeoplasiaHuman Papillomavirus InfectionCervical Precancer
Basic Health International, Inc.5,000 enrolled1 locationNCT07461818
Recruiting
Not Applicable

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

Cervical CarcinomaHuman Papillomavirus Infection
National Cancer Institute (NCI)500 enrolled18 locationsNCT07281430
Recruiting

Role of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring

Cervical CancerOropharyngeal CancerCervical Dysplasia+1 more
The Institute of Molecular and Translational Medicine, Czech Republic480 enrolled1 locationNCT05774561
Recruiting
Phase 4

Zopa Retreatment and Vector Shedding in Adults With RRP

Recurrent Respiratory PapillomatosisPapillomavirus InfectionPapillomaviridae
Precigen, Inc30 enrolled3 locationsNCT06538480
Recruiting

Impact of an e-Bug Educational Intervention on HPV Vaccine Uptake in Middle School Students

Papillomavirus InfectionPapillomavirus VaccinesVaccination Coveage
Centre Hospitalier Universitaire de Nice11,000 enrolled1 locationNCT07266857
Recruiting
Phase 1Phase 2

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Advanced Solid TumorsCarcinomaNeoplasms+9 more
Marengo Therapeutics, Inc.365 enrolled32 locationsNCT05592626
Recruiting
Phase 4

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

Papillomavirus InfectionHuman Immunodeficiency VirusCervical Intraepithelial Neoplasia+4 more
Louisiana State University Health Sciences Center in New Orleans250 enrolled1 locationNCT05266898
Recruiting
Not Applicable

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

Human Papillomavirus Infection
The University of Texas Health Science Center, Houston2,142 enrolled1 locationNCT06598475
Recruiting

Negative HPV Test Results on Infinity/GeneXpert® With the Presence of a Late Amplification Signal: What Does This Mean ? (PaPCR)

Cervical CancersPapillomavirus InfectionsPapillomavirus Type 16/18 Infection
University Hospital, Brest47 enrolled1 locationNCT06919627
Recruiting

Normalizing Antibody Detection in First-void Urine

Human Papillomavirus Infection
Universiteit Antwerpen150 enrolled1 locationNCT06582654
Recruiting
Not Applicable

HPV Self-sampling for Women Who do Not Attend Cervical Cancer Screening Programme

Cervix CancerEarly Detection of CancerPapillomavirus Infections+1 more
Universidade do Porto1,000 enrolled2 locationsNCT06371118
Recruiting
Not Applicable

Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy

Human Papillomavirus InfectionVaccination Hesitancy
University of Virginia220 enrolled1 locationNCT05860725
Recruiting

Observational Study of Viral BIOmarkers and microRNAs in Tumors Orofarynx and Occult Tumors Positive for Papilloma Virus

Lymph Node MetastasisLiquid BiopsySquamous Cell Carcinoma of the Oropharynx+3 more
Regina Elena Cancer Institute142 enrolled1 locationNCT05918510